Searchable abstracts of presentations at key conferences in endocrinology

ea0026p11 | Adrenal cortex | ECE2011

Arthritis after removal of adrenal adenoma in Cushing’s syndrome

Ungureanu Maria-Christina , Cernohuz Adriana , Gorduza Carmen , Scripcariu Viorel , Vulpoi Carmen , Preda Cristina

Endogenous hypercortisolism is a well-known immunosuppressive condition. Such endogenous cortisol secretion could suppress the clinical presentation of an ongoing autoimmune process.A 49-year-old woman was admitted in our service in august 2010 for Cushing clinical signs, arterial hypertension and hypokalemia. She had high plasma cortisol not suppressed by 1 and 8 mg dexamethasone overnight, low ACTH. Abdominal computed tomography demonstrated a tumor (3...

ea0016p435 | Neuroendocrinology | ECE2008

Lymphocytic infundibulo-neurohypophysitis with diabetes insipidus and favorable evolution after glucocorticoid treatment

Ungureanu Maria-Christina , Luca Ioana , Grigoras Mihai , Gorduza Carmen , Vulpoi Carmen , Zbranca Eusecie

Infundibulohypophysitis is an unusual inflammatory condition that affects the infundibulum, the pituitary stalk and the neurohypophisis and may be a part of a range that includes lymphocityc hypophysitis. It occurs mainly in women and most often presents in later stages of pregnancy. Infundibilohypophysitis usually presents with diabetes insipidus. The case of a 30-year-old woman with diabetus insipidus diagnosticated in the third trimester of the pregnancy is reported. She wa...

ea0016p795 | Thyroid | ECE2008

Graves’ disease and myasthenia gravis: who comes first?

Vulpoi Carmen , Andriescu Lidia , Ciobanu Delia Gabriela , Ungureanu Maria Christina , Cuciureanu Dan , Grigoras Mihai , Zbranca Eusebie

Graves’ disease (GD) and myasthenia gravis (MG) may be associated and influence one another clinical expression. We report the cases of 3 female patients who presented this particular association. First patient (RL, 55 years), was diagnosed with MG and, 5 years after, developed GD, remitted after 2 years of anti-thyroid drugs (ATD). She is still euthyroid after more than 10 years, and MG is compensated with moderate doses of anticholinesterase drugs (ACD). Thoracic CT sho...

ea0056p35 | Adrenal cortex (to include Cushing's) | ECE2018

A four months infant survival case of waterhouse–friderichsen syndrome

Teodoriu Laura , Teodor Danut , Ungureanu Maria-Christina , Leustean Letitia , Ioan Bianca , Preda Cristina

Introduction: The Waterhouse–Friderichsen syndrome is a fulminating infection, often leading to mortality in a matter of hours by producing acute adrenal insufficiency (adrenal hemorrhage) at a time when their response is crucial to address acute stress.Case report: We present the case of a 4 months boy with high fever 40 °C, vomiting, diarrhea, lethargy, maculopapular rash followed by petechiae and purpura. Biological tests revealed important ...

ea0073aep150 | Calcium and Bone | ECE2021

Symptomatic mastoidian brown tumor in a dialysed child

Anisia Miruna , Dumitru Teodora , Ungureanu Maria Christina , Preda Cristina , Magdalena Starcea , Leustean Letitia

Brown tumors (BT) consist of focal bone lesions, caused by increased osteoclastic activity and fibroblastic proliferation. They appear in chronic kidney disease (CKD) as a result of renal osteodystrophy with high bone turnover, due to secondary hyperparathyroidism. BT are composed of mononuclear stromal cells mixed with multinucleated giant cells and hemosiderin deposits, which give the characteristic brown colour. We present the case of a 13-year-old girl, with end-stage CKD ...

ea0081ep86 | Adrenal and Cardiovascular Endocrinology | ECE2022

Head and neck paraganglioma: exploring the metastasizing potential. Case report

Teodoriu Laura , Boboc Andreea , Patrascu Ana-Maria , Bilha Stefana , Leustean Letitia , Ungureanu Maria-Christina , Stefanescu Cipriana , Preda Cristina

Introduction: Paragangliomas (PGLs) are tumors originating from neural crest-derived cells situated in the region of the autonomic nervous system ganglia. Head-and-neck PGLs (HNPGLs) originate from the sympathetic and parasympathetic paraganglia, most frequently from the carotid bodies and jugular, tympanic and vagal paraganglia, and are usually non-catecholamine secreting.Case report: We present the case of a 60 years old male patient, which was admitte...

ea0081ep1206 | Late Breaking | ECE2022

The impact of gh treatment in turner syndrome

Hrisca Anamaria , Dumitru Teodora , Andrei Diana , Florescu Alexandru , Leustean Letitia , Rusu Cristina , Preda Cristina , Ungureanu Maria Christina

Introduction: The treatment with growth hormone (GH) plays an essential role in the Turner syndrome (TS) management. This study evaluated its efficacy in improving adult height (AH) and metabolic parameters.Material and methods: We retrospectively analysed auxological, biochemical, genetic and pharmacological parameters of 56 girls with confirmed TS. They were categorised according to their karyotype as X monosomy (62%), isochromosome (17%), X mosaicism ...

ea0063p490 | Calcium and Bone 2 | ECE2019

Hyperparathyroidism – jaw tumor syndrome – differential diagnostic traps

Nechita Mirela Claudia , Tudurean-Olteanu Anca Georgiana , Costan Victor Vlad , Danila Radu , Preda Cristina , Ungureanu Maria Christina

Introduction: Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome is a rare genetic disorder bearing a germline and a somatic CDC73 mutation. The features of HPT-JT are clinically difficult to ascertain because the parathyroid disease, ossifying fibroma in the jaw and other abnormalities, often occurs asynchronously and may be diagnosed and treated separately. The association of jaw ossifying fibroma with primary hyperparathyroidism (PHPT) is typical of HPT-JT.<p class="abstex...

ea0063p741 | Pituitary and Neuroendocrinology 2 | ECE2019

Ongoing challenges in treatment of cushing’s disease due to pituitary macroadenoma

Teuşan Teodora , Ciobotar Mihaela , Florescu Alexandru , Ungureanu Maria Christina , Mogoş Voichiţa , Leuştean Letiţia

Introduction: Cushing’s disease (CD) is five to six times more common than Cushing’s syndrome, with a peak incidence at 20–40 years. It is usually an ACTH-secreting microadenoma, the local invasion being associated with one third of macroadenomas. The treatment of choice is the transsphenoidal surgery, but nearly 50% of the patients with macroadenomas ultimately require additional treatment. Cabergoline appears to be an attractive treatment option for CD, consid...

ea0063ep105 | Pituitary and Neuroendocrinology | ECE2019

Therapeutic challenges in a case of TSH/GH co-secreting pituitary macroadenoma

Hrisca Anamaria , Balineanu Ginuta , Tudurean-Olteanu Georgiana , Nechita Mirela , Potorac Iulia , Leustean Letitia , Preda Cristina , Ungureanu Maria Christina

Introduction: Thyrotropin-secreting pituitary adenomas are rare tumors accounting for 1–2% of all pituitary adenomas and the diagnosis is based on the combination of high fT4 levels with normal to high TSH concentration in the presence of a pituitary adenoma. About one third co-secrete other hormones, of which, most frequently growth hormone (16%) followed by prolactin and gonadotropins.Case report: A 60 years-old male patient presented in 2016 afte...